MAD2L2 and central nervous system cancer: Finally, we calculated the tumor mutation burden (TMB) and found that the expression of MAD2L2 was highly associated with OVCA patients’ TMB, and the highest correlation ratio with MAD2L2 level was found in the low-grade glioma (Fig. 1C).